Ultra high field
Showing 9976 - 10000 of >10,000
Muscular Endurance, Fatigue (Multiple Sclerosis).
Not yet recruiting
- Multiple Sclerosis
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Oct 12, 2023
Osteoporosis Risk Trial in Gölhisar (Exercise)
Completed
- Osteoporosis Risk
- Exercise
-
Gölhisar, Burdur, TurkeyBurdur Mehmet Akif Ersoy University
Oct 10, 2023
Muscular Dystrophy, Facioscapulohumeral Trial in Leiden (CHDR Monitoring Remotely (MORE), Withings Steel HR, Withings Body+
Completed
- Muscular Dystrophy, Facioscapulohumeral
- CHDR Monitoring Remotely (MORE)
- +3 more
-
Leiden, Zuid Holland, NetherlandsCentre for Human Drug Research
Mar 8, 2022
Evaluating the Impact of a Supportive Care Program
Enrolling by invitation
- Patient Engagement
- Morality
- Supportive care program
-
New York, New YorkNYU Langone Health
Jul 13, 2022
Endoscopic Ultrasonography, Pancreatic Disease, Bile Duct Diseases Trial in Wuhan (AI-based biliopancreatic EUS navigation
Recruiting
- Endoscopic Ultrasonography
- +3 more
- AI-based biliopancreatic EUS navigation system
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
Jul 9, 2022
Clinical High Risk for Developing Psychosis Trial in Calgary (Supportive therapy and CBT)
Recruiting
- Clinical High Risk for Developing Psychosis
- Supportive therapy and CBT
-
Calgary, Alberta, CanadaMathison Centre for Research and Education, University of Calgar
May 17, 2022
Emotional Disturbances, Depression, Pregnancy Late Trial in Bronx, Columbus (COPE-P)
Active, not recruiting
- Emotional Disturbances
- +5 more
- COPE-P
-
Bronx, New York
- +2 more
May 2, 2022
Osteoarthritis Trial in United States (Povidone iodine, Vancomycin powder, Conventional)
Recruiting
- Osteoarthritis
- Povidone iodine
- +2 more
-
Rancho Mirage, California
- +13 more
Dec 30, 2022
Resectable Hepatocellular Carcinoma Trial in Tianjin (Camrelizumab:200mg, iv,d1 q2w;apatinib:250mg,po,qd,q2w)
Recruiting
- Resectable Hepatocellular Carcinoma
- Camrelizumab:200mg, iv,d1 q2w;apatinib:250mg,po,qd,q2w
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Insititute and Hospital
Nov 3, 2021
Elimination of Hepatitis C Virus Among Users of Substances
Not yet recruiting
- Hepatitis C in Substance Users
- Sofosbuvir 400 MG / Velpatasvir 100 MG [Epclusa]
- (no location specified)
Aug 14, 2022
Peripheral Artery Disease Trial in Leipzig (Ranger Drug Eluting Balloon, In Pact Drug Eluting Balloon)
Active, not recruiting
- Peripheral Artery Disease
- Ranger Drug Eluting Balloon
- In Pact Drug Eluting Balloon
-
Leipzig, Saxony, GermanyUniversity Clinic Leipzig
Dec 13, 2021
Stage III Oropharyngeal Squamous Cell Carcinoma, Stage IVA Oropharyngeal Squamous Cell Carcinoma, Stage IVB Oropharyngeal
Active, not recruiting
- Stage III Oropharyngeal Squamous Cell Carcinoma
- +4 more
- Cisplatin
- +2 more
-
Birmingham, Alabama
- +221 more
Sep 7, 2022
Radioactive Brain Damage of Nasopharyngeal Carcinoma Based on
Recruiting
- Nasopharyngeal Carcinoma
- intensity-modulated radiation therapy
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Sep 15, 2022
Type 2 Diabetes Trial in United States (Automated health education using a digital health pathway)
Recruiting
- Type 2 Diabetes
- Automated health education using a digital health pathway
-
Chicago, Illinois
- +3 more
Sep 16, 2022
Treated Neurocysticercosis and Long-Term Outcomes
Recruiting
- Cysticercosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Femoral Fracture Trial in San Diego (RFN-Advanced Retrograde Femoral Nailing System)
Recruiting
- Femoral Fracture
- RFN-Advanced Retrograde Femoral Nailing System
-
San Diego, CaliforniaUniversity of California, San Diego
Jan 9, 2023
Intracardiac Hemodynamics and Myocardial Strain in Athletes
Completed
- Cardiac Structure and Function
- Intracardiac Hemodynamic
- exercise
-
Chengdu, Sichuan, ChinaChengdu Sport University
Oct 3, 2023
Cardiac Exposure Following Breast Radiotherapy
Completed
- Breast Cancer
- Research Cardiac MRI
- Biomarkers
-
Detroit, MichiganHenry Ford Health System
Feb 17, 2022
Blood Flow Regulation in Glaucoma
Completed
- Glaucoma
- Isometric exercise
-
Vienna, AustriaMedical University of Vienna
Aug 31, 2021
Healthy Subjects Trial in Moscow (High-Resolution anorectal manometry with the use of solid-state catheter)
Recruiting
- Healthy Subjects
- High-Resolution anorectal manometry with the use of solid-state catheter
-
Moscow, Russian Federation
- +1 more
Feb 2, 2022
Healthy Subjects Trial in Moscow (High resolution anorectal manometry, water perfused catheter)
Recruiting
- Healthy Subjects
- High resolution anorectal manometry, water perfused catheter
-
Moscow, Russian Federation
- +1 more
Feb 2, 2022
Hernia Incisional Trial in Leon (Mesh reinforcement, RTL reinforcement)
Completed
- Hernia Incisional
- Mesh reinforcement
- RTL reinforcement
-
Leon, Guanajuato, MexicoHospital regional de Alta Especialidad del bajio
Feb 9, 2022
Healthy Trial in Portland (Xanthohumol, Placebo oral capsule)
Active, not recruiting
- Healthy
- Xanthohumol
- Placebo oral capsule
-
Portland, OregonHelfgott Research Institute National University of Natural Medic
Nov 10, 2021
Soft Tissue Sarcoma Trial in Iowa City (Ascorbate)
Recruiting
- Soft Tissue Sarcoma
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Jun 25, 2021
High Density Lipoprotein Function in Type 1 Diabetic Nephropathy
Recruiting
- Type 1 Diabetes
- Blood samples
- Urine sample
-
Dijon, FranceChu Dijon Bourogne
Jun 8, 2022